COVID vaccine

COVAXIN

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against the Delta variant. In a pre-print paper that is yet to be peer-reviewed, the company claimed that the vaccine is also 63 per cent effective …

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Read More »

MINISTRY OF HEALTH AND FAMILY WELFARE

Breaking: Union Health Ministry Writes to States & UTs on Allocation of COVID Vaccine

Union Health Ministry has written to States/ UTs on allocation of COVID vaccine doses during May & first fortnight of June from Govt of India channel, & availability of Vaccine doses that can be procured directly by States & private hospitals during May and June 2021: Government of India According to the advance visibility provided …

Breaking: Union Health Ministry Writes to States & UTs on Allocation of COVID Vaccine Read More »

Covid vaccination

Bleeding and clotting events following COVID vaccination miniscule in India

Bleeding and clotting cases following COVID vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the National AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health & Family Welfare said. Alerts have been raised in some countries on …

Bleeding and clotting events following COVID vaccination miniscule in India Read More »

Covaxin

DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021. …

DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years Read More »

United States of America

US approves Corona vaccine for children between 12 and 15 years

The US has approved Pfizer-BioNTech’s Covid-19 vaccine for people between 12 and 15 years of age, making it the first for children. US Food and Drug Administration (FDA) expanded emergency use authorization for the Pfizer shot to include youths aged 12-15. Shots could begin as soon as tomorrow, after a federal vaccine advisory committee issues …

US approves Corona vaccine for children between 12 and 15 years Read More »

images

Hyundai Motor India Foundation announces roll-out of COVID-19 relief measures

Hyundai Motor India Foundation, the philanthropic arm of Hyundai Motor India, in continuation of its ongoing COVID-19 relief programs, on Wednesday announced a series of initiatives to offer infrastructural assistance to most affected states of Maharashtra, Telangana, Tamil Nadu, Delhi and Haryana. Under its third phase of initiatives  for COVID-19, Hyundai Motor India Foundation will …

Hyundai Motor India Foundation announces roll-out of COVID-19 relief measures Read More »

Serum_Institute_of_India

Serum Institute of India (SII) reduces price of COVID-19 vaccine COVISHILED from Rs 400 to Rs 300

The Serum Institute of India has reduced the price of its COVID vaccine ‘ COVISHIELD’ from Rs 400 to Rs 300 per dose for states, as announced by CEO Adar Poonawala. Mr. Poonawala tweeted, “ As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from …

Serum Institute of India (SII) reduces price of COVID-19 vaccine COVISHILED from Rs 400 to Rs 300 Read More »

SC

Supreme Court asks Centre to explain rationale adopted in COVID 19 vaccine pricing

The Supreme Court has asked the Union of India (UOI) to explain the basis and rationale adopted with respect to pricing of COVID vaccines and other necessary items.  The apex court said each of the state government has to file their respective replies by Thursday 6 pm in connection with their respective states with regard …

Supreme Court asks Centre to explain rationale adopted in COVID 19 vaccine pricing Read More »

Employees of Work Places (Government and Private) aged 45 Years or More to be Vaccinated at Work Place Vaccination Centres from 11 April 2021

The Health Ministry has written to all States and UTs that COVID-19 vaccination sessions may now be organized at workplaces (both public & private) which are having about 100 eligible and willing beneficiaries by tagging these workplaces with an existing COVID Vaccination Center (CVC). To support the States in this initiative, guidelines have been prepared and the same have conveyed by the Union Health Secretary to the States and UTs. These guidelines will support the State and District Programme Managers with the requisite information and guide them on organizing vaccination sessions at such workplaces (both public & private). Such work place vaccination centres may be launched across States/UTs from 11th April 2021.